Rainbow Childrens Medicare Ltd.

NSE: RAINBOW · Healthcare

₹1,244.40-1.39%06 Nov 2026

Ask the data

Instant answers about Rainbow Childrens Medicare Ltd. — computed from its filings, no language model

Market cap₹12,639 cr

Current price₹1,244.40

High / Low₹1,599 / ₹1,104

P/E43.2

P/B7.37

Book value₹168.8

ROE17.0%

ROCE27.1%

Debt / equity0.00

Dividend yield0.24%

EPS (TTM)₹28.77

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY22	FY23	FY24	FY25	FY26
Revenue	974	1,174	1,297	1,516	1,703
EBITDA	305	396	429	490	544
Operating margin	31.3%	33.8%	33.1%	32.3%	32.0%
Interest	53	55	59	72	78
Depreciation	83	90	112	138	151
Profit before tax	187	282	295	330	358
Tax	49	69	77	86	77
Net profit	138	211	217	243	278
EPS ₹	14.75	20.89	21.38	23.97	27.41
Operating cash flow	224	327	321	396	420
Capex	62	141	354	146	216
Dividend paid	9	20	31	30	30
Total assets	1,296	1,776	2,170	2,377	2,775
Equity	603	1,060	1,259	1,468	1,648

Quarterly performance

last 19 quarters · ₹ crore

showing latest 8 of 19 periods

	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	212	237	313	306	317	287	333	336	341	330	417	398	370	353	445	445	460	470	548
Operating profit	48	82	110	107	98	88	118	118	106	94	147	134	115	104	149	147	145	135	170
Operating margin	22.7%	34.6%	35.0%	34.8%	30.9%	30.5%	35.3%	35.1%	30.9%	28.4%	35.2%	33.8%	31.0%	29.4%	33.5%	33.0%	31.5%	28.6%	31.0%
Other income	6	6	8	8	9	8	8	9	13	12	11	13	15	20	8	11	5	13	8
Interest	16	14	13	14	14	15	13	14	17	18	18	18	18	18	19	20	20	21	22
Depreciation	22	22	22	23	23	25	27	28	32	34	35	35	34	34	36	40	41	42	45
Profit before tax	16	52	81	78	70	56	85	85	69	53	105	94	77	71	102	98	87	84	112
Tax	4	13	20	20	16	14	22	22	18	14	26	25	20	18	27	24	9	21	28
Net profit	12	38	61	58	54	41	63	62	51	40	79	69	56	54	75	73	77	61	82
EPS ₹	1.36	3.78	6.06	5.74	5.31	4.04	6.20	6.12	5.02	3.89	7.77	6.76	5.55	5.27	7.41	7.14	7.59	5.97	8.10
Revenue YoY	—	—	—	—	49.2%	21.1%	6.3%	9.6%	7.6%	15.0%	25.5%	18.5%	8.5%	6.9%	6.5%	11.9%	24.3%	33.2%	23.2%
Profit YoY	—	—	—	—	339.6%	7.3%	2.9%	7.3%	-4.9%	-3.6%	25.4%	10.6%	10.5%	35.3%	-4.6%	5.6%	36.7%	13.2%	9.1%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 16 periods

	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	17.9%	19.9%	20.2%	18.9%	19.3%	17.2%	17.1%	17.2%	17.7%	16.6%	17.5%	16.7%	17.0%	16.9%	17.3%	17.0%
ROCE	30.1%	31.8%	32.2%	30.3%	30.9%	28.1%	28.2%	28.3%	29.3%	27.4%	28.6%	27.5%	27.9%	26.4%	27.4%	27.1%
Net margin	15.8%	18.0%	17.5%	17.3%	17.3%	16.7%	16.1%	16.2%	16.0%	16.1%	16.7%	16.2%	16.0%	16.3%	15.7%	15.2%
EBITDA margin	32.4%	33.8%	32.9%	33.0%	33.1%	33.1%	32.5%	32.6%	32.3%	32.3%	32.5%	32.0%	31.9%	32.0%	31.6%	31.0%
Debt / equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest coverage	4.96	6.10	6.13	6.20	6.25	5.99	5.67	5.64	5.53	5.55	5.81	5.72	5.63	5.61	5.59	5.53
Asset turnover	0.65	0.66	0.69	0.66	0.67	0.60	0.62	0.63	0.66	0.64	0.65	0.61	0.62	0.61	0.66	0.65

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 11 periods

	MAR '21‡	MAR '22‡	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	55	105	102	102	102	102	102	102	102	102	102
Other equity / reserves	391	498	845	958	1,038	1,157	1,242	1,367	1,416	1,547	1,612
Total equity	446	603	946	1,060	1,139	1,259	1,343	1,468	1,518	1,648	1,714
Borrowings	48	42	0	0	0	0	0	0	0	0	0
Current liabilities	122	125	129	144	127	149	160	151	208	184	218
Non-current liabilities	511	564	556	567	626	756	753	751	845	927	1,004
Total assets	1,081	1,296	1,636	1,776	1,898	2,170	2,262	2,377	2,587	2,775	2,959
Property, plant & equipment	399	419	873	928	971	1,249	1,403	1,388	1,451	1,562	1,669
Capital work-in-progress	29	5	29	21	69	14	17	28	53	76	103
Investments	18	22	0	58	147	308	423	571	416	404	354
Inventories	10	15	20	19	17	24	28	28	40	42	54
Receivables	44	40	63	58	65	70	95	77	107	103	133
Cash & equivalents	6	10	122	15	13	10	15	20	27	34	33

Cash flow

annual · ₹ crore · line = free cash flow

showing latest 5 of 6 periods

	FY21‡	FY22	FY23	FY24	FY25	FY26
Cash from operations	143	224	327	321	396	420
Cash from investing	-83	-175	-465	-226	-268	-259
Cash from financing	-61	-44	143	-102	-118	-147
Capex	76	62	141	354	146	216
Free cash flow	67	162	186	-32	250	203
Dividends paid	0	9	20	31	30	30

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,669 cr56%

CWIP

₹103 cr3%

Investments

₹354 cr12%

Inventories

₹54 cr2%

Receivables

₹133 cr5%

Cash & equivalents

₹33 cr1%

Other assets

₹613 cr21%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Rainbow Childrens Medicare Ltd.	12,639	1,244.40	43.2	7.37	17.0%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-2.1%

6 months-3.7%

1 year-10.4%

3Y CAGR+6.7%

5Y CAGR—

10Y CAGR—

50-day avg₹1,330.81

200-day avg₹1,320.53

RSI (14)49

Compare Rainbow Childrens Medicare Ltd. with

Cohance Lifesciences vs Rainbow Childrens Medicare Poly Medicure vs Rainbow Childrens Medicare Vijaya Diagnostic Centre vs Rainbow Childrens Medicare NATCO Pharma vs Rainbow Childrens Medicare Rainbow Childrens Medicare vs Concord Biotech

FAQs

What is the share price of Rainbow Childrens Medicare Ltd.?

Rainbow Childrens Medicare Ltd. (RAINBOW) closed at ₹1,244.40 on NSE on 06 Nov 2026.

What is the market cap of Rainbow Childrens Medicare Ltd.?

₹12,639 crore at the latest close.

What is the P/E ratio of Rainbow Childrens Medicare Ltd.?

43.2, on trailing-twelve-month earnings from its filings.

How fast is Rainbow Childrens Medicare Ltd. growing?

Rainbow Childrens Medicare Ltd.: revenue has compounded at 13.2% a year over three years; net profit at 9.7% a year. Latest-quarter revenue is up 23.2% year on year, profit up 9.1%.

How profitable is Rainbow Childrens Medicare Ltd.?

On a trailing-twelve-month basis return on equity is 17.0%, return on capital employed 27.1%, operating margin 31.0%, net margin 15.2%.

How much debt does Rainbow Childrens Medicare Ltd. have?

Rainbow Childrens Medicare Ltd. is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹33 cr (balance sheet of 2026-09-30). Operating profit covers interest 5.5 times.

Financials parsed from Rainbow Childrens Medicare Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '22, annual from FY22, balance sheet from Mar '21. * = derived (full year or half year minus earlier quarters). ‡ = balance sheet / cash flow read from the company's published annual report (same basis), for years before the NSE filings carry them; each one checked to add up. Information only, not investment advice.